M&A / Deals AI giant Anthropic buys Coefficient Bio for $400m PharmaphorumAnthropic has continued its push into the healthcare sector by acquiring New York start-up Coefficient Bio.M&A / DealsRead full story pharminent April 7, 2026 (Last updated: April 7, 2026) Pharmaphorum Anthropic has continued its push into the healthcare sector by acquiring New York start-up Coefficient Bio. M&A / DealsRead full story Post navigation Previous: Amgen Seeks ‘Return to Growth’ for Tepezza as More Convenient Formulation Aces Phase 3Next: Sanofi immune drug hopeful posts mixed results in mid-stage tests Related Stories M&A / Deals BioMarin spends up to $490m for Alesta’s bone disease candidate pharminent August 19, 2026 M&A / Deals J&J hands lymphoma bispecific CAR T back to AbelZeta pharminent August 17, 2026 M&A / Deals Novo Nordisk and AWS form AI partnership to speed drug discovery pharminent August 17, 2026
